International Footprint

We currently have our own sales and marketing organisations in 12 Western European countries and in the USA. We also market products in over 40 countries worldwide through distributors and marketing partners. A number of these countries are currently being evaluated to assess the opportunity to extend our own sales and marketing capabilities thereby maximising margin return for the Group.

The map below shows the number of key products in our focused therapeutic areas in territories where we have sales and marketing organisations.

"The majority of our products are novel or have clear marketing advantages over competitor products."

Read more about our Key products and Specialisations

Click map to interect

  • Key
  • European Pharmaceuticals
  • US Pharmaceuticals
  • Export
  • Number of key products